The cloud-based Accelrys HEOS information management and collaboration workspace is now live on the BT for Life Sciences R&D cloud platform. BT for Life Sciences R&D provides a secure, reliable and scalable cloud environment for HEOS users, enabling more efficient and productive networked collaboration by pharmaceutical research organisations and their partners.
This latest engagement between BT and Accelrys furthers the relationship on hosting and externalisation that has been in place between the companies since April 2012, while strengthening the enterprise capabilities of the recently announced Accelrys Externalized Collaboration Suite. Combined with the enterprise cloud infrastructure provided by BT, the suite addresses the needs of research organisations transitioning to an externalised network research environment.
‘BT’s robust Life Sciences for R&D cloud service is essential to meeting the critical business issues raised by externalised network research today,’ said Bas Burger, president of Global Pharmaceutical & Chemical for BT Global Services. ‘Combining Accelrys HEOS and other Accelrys applications for externalised research as part of BT for Life Sciences R&D enables scientists working in pharmaceutical and biotechnology companies, as well as academia and government, to collaborate effectively in a cloud environment. The platform is designed to allow customers to comply with the industry’s stringent security, regulatory and compliance requirements.’
